Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies
Pharmacophore · 2024 · 15 (2) · 32-42
DOI: 10.51847/tib6u3aef5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacophore, 2024. Verfasst von Cosmin Mihai Vesa und 6 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Momordica charantia (MC), commonly known as bitter melon, has garnered attention for its diverse pharmacological properties, particularly its potential in managing diabetes mellitus (DM) and associated complications. The present narrative review comprehensively assesses the scientific landscape surrounding MC's efficacy and safety in the context of diabetes and its related complications, encompassing neuropathy, nephropathy, impaired wound healing, retinopathy, dyslipidemia, fatty liver dise
Zitieren
APA
Vesa, C. M., Bungau, S. G., Tit, D. M., Purza, A. L., Bungau, A. F., Radu, A. F., & Stoicescu, M. (2024). Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies. Pharmacophore, 15(2), 32-42. https://doi.org/10.51847/tib6u3aef5
Vancouver
Vesa CM, Bungau SG, Tit DM, Purza AL, Bungau AF, Radu AF, et al. Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies. Pharmacophore. 2024;15(2):32-42. doi:10.51847/tib6u3aef5
BibTeX
@article{Vesa2024,
author = {Vesa, Cosmin Mihai and Bungau, Simona Gabriela and Tit, Delia Mirela and Purza, Anamaria Lavinia and Bungau, Alexa Florina and Radu, Andrei Flavius and Stoicescu, Manuela},
title = {Exploring the Impact of Momordica charantia on Diabetes Mellitus: From Cell Cultures to Clinical Studies},
journal = {Pharmacophore},
year = {2024},
volume = {15},
number = {2},
pages = {32--42},
doi = {10.51847/tib6u3aef5}
}
EUVIMED